Clinical Trial Update: A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical study evaluating a genetics-based approach to dosing chemotherapy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN